Alivus Life Sciences Q4 Results
- BSE: 543322
- NSE: ALIVUS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
1,383.05
-8.80 (-0.63%)
-8.80 (-0.63%)Volume6.20 K
Updated: Fri 11 Sep, 2026 | 15:28:58
NSE
1,386.80-3.40 (-0.24%)
-3.40 (-0.24%)Volume74.37 K
Updated: Fri 11 Sep, 2026 | 15:51:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Alivus Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 494.79 | 486.93 | 1.61% | 409.69 | 5.93% |
| Depreciation/ Amortization | 20.20 | 19.66 | 2.76% | 14.53 | 26.49% |
| Operating Income | 194.33 | 185.96 | 4.50% | 126.91 | 6.50% |
| Net Income | 162.66 | 150.26 | 8.25% | 97.94 | 14.66% |
| Other Operating Expenses Total | 125.62 | 98.83 | 27.11% | 84.20 | 23.40% |
| Net Income Before Taxes | 215.80 | 198.39 | 8.77% | 129.68 | 12.81% |
| Total Revenue | 689.12 | 672.89 | 2.41% | 536.60 | 6.09% |
| Selling/ General/ Admin Expenses Total | 78.12 | 66.37 | 17.71% | 72.26 | 17.09% |
| Diluted Normalized EPS | 13.22 | 13.80 | -4.21% | 7.97 | 14.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.